WT
VKTX icon

Whittier Trust’s Viking Therapeutics VKTX Stock Holding History

Whittier Trust’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11
Closed -$696 – 1607
2024
Q3 		$696 Hold
11
– – ﹤0.01% 1506
2024
Q2 		$583 Sell
11
-12,000
-100% -$787K ﹤0.01% 1485
2024
Q1 		$985K Buy
+12,011
New +$534K 0.01% 363
2019
Q4 		– Sell
-453
Closed -$3K – 1614
2019
Q3 		$3K Buy
+453
New +$3.37K ﹤0.01% 1338

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Whittier Trust's VKTX Position: Q4 2024 in Review

Whittier Trust sold out of Viking Therapeutics (VKTX) in Q4 2024, closing a stake of 11 shares — an estimated $696 sold.

Whittier Trust first reported a position in VKTX in Q3 2019 and held it in 4 quarters. The position peaked at $985K in Q1 2024. 408 funds tracked by Wall St. Rank hold VKTX as of Q4 2024.

  • Whittier Trust reported no remaining Viking Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Whittier Trust sold 11 Viking Therapeutics shares in Q4 2024, an estimated $696.
  • Whittier Trust first reported a position in Viking Therapeutics in Q3 2019 and held it in 4 quarters.
  • Whittier Trust's Viking Therapeutics position peaked at $985K in Q1 2024.
  • 408 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2024.

Based on Whittier Trust's 13F filing for Q4 2024, filed 11 Feb 2025.